首页> 中文期刊> 《中国继续医学教育》 >盐酸氨溴索支气管肺泡灌洗联合肺表面活性物质对新生儿胎粪吸入综合征的治疗效果

盐酸氨溴索支气管肺泡灌洗联合肺表面活性物质对新生儿胎粪吸入综合征的治疗效果

         

摘要

Objective To explore the clinical curative effect of ambroxol bronchoalveolar lavage with pulmonary surfactant syndrome on neonatal meconium aspiration.MethodsA retrospective analysis of 125 cases of neonatal meconium inhalation syndrome patients were selected as the research object from April 2015 to April 2016 , the patients were divided into control group (62 cases), study group (63 cases), control group was treated with ambroxol bronchoalveolar lavage in the treatment of, research group in the control group based on the uplink of pulmonary surfactant treatment, observed the clinical effect of the two groups and the incidence of complications.ResultsThe time of mechanical ventilation and hospital stay in the study group were signiifcantly lower than those in the control group, the difference was statistically significant (P<0.05).Conclusion Ambroxol bronchoalveolar lavage with pulmonary surfactant can be effective in the treatment of neonatal meconium inhalation syndrome, shorten the hospitalization time, and duration of mechanical ventilation.%目的:探究盐酸氨溴索支气管肺泡灌洗联合肺表面活性物质对新生儿胎粪吸入综合征的临床疗效。方法回顾性分析选取2015年4月~2016年4月收治的125例新生儿胎粪吸入综合征患儿临床资料作为研究对象,将其分为对照组(62例)、研究组(63例),对照组行盐酸氨溴索支气管肺泡灌洗治疗,研究组在对照组基础上行肺表面活性物质治疗,观察两组临床效果以及并发症发生率。结果研究组患儿机械通气时间与住院时间显著低于对照组,差异具有统计学意义(P<0.05)。结论盐酸氨溴索支气管肺泡灌洗联合肺表面活性物质能够有效治疗新生儿胎粪吸入综合征,缩短患儿住院时间以及机械通气时间。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号